Canaccord Genuity Maintains a 'Buy' on Meridian Biosciences (VIVO); Q3 Preview: Performing Well Despite Hurdles
Tweet Send to a FriendGet Alerts VIVO Hot Sheet
Price: $21.89 +1.06%
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade VIVO Now!
Canaccord Genuity maintains a 'Buy' on Meridian Biosciences (NASDAQ: VIVO) price target of $25.00.
Analyst, Jeffrey Frelick, said, "We expect VIVO to report Fiscal Q3 2012 sales of $46.6M (+16%) and EPS of $0.22, matching the consensus estimates."
"Despite weakness in Europe and some C. diff. share loss to Alere (NYSE: ALR), VIVO is performing well in its core sales categories. We are encouraged by the performance of the sales force to drive placements of Illumigene. We think a relatively strong core sales mix together with near-term product approvals keeps us positive on the stock."
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $19.63 yesterday, with a 52 week range of $14.81-$27.37.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jeffrey Frelick, said, "We expect VIVO to report Fiscal Q3 2012 sales of $46.6M (+16%) and EPS of $0.22, matching the consensus estimates."
"Despite weakness in Europe and some C. diff. share loss to Alere (NYSE: ALR), VIVO is performing well in its core sales categories. We are encouraged by the performance of the sales force to drive placements of Illumigene. We think a relatively strong core sales mix together with near-term product approvals keeps us positive on the stock."
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $19.63 yesterday, with a 52 week range of $14.81-$27.37.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
- RBC Capital Lifts PT on Marvell (MRVL) after 'Strong' Q1 Report
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
